DevOps platform for digital health, blueBriX has introduced new micros frontends for its Patient Support Program and Remote Patient Monitoring modules, allowing easy integration into digital health applications and improving standards of care.
The company has developed and integrated micro frontends to enable application developers, healthcare providers and pharma to fill feature gaps and enhance existing applications without having to build new technology from scratch.
Micro frontend architecture breaks down monolithic applications into smaller, independent frontend modules, delivering improved scalability, modularity and user experience.
With the new micro frontends, bluBrix has been able to develop and integrate new features into the Patient Support Program and Remote Patient Monitoring modules. As a result, healthcare providers can track and facilitate medication adherence, enhance patient education and improve assistance for chronic conditions.
In addition, the company has developed and integrated a dedicated analytics module. This allows users to collate data from the blueBriX platform as well as collate and integrate data from other administrative or clinical applications used in healthcare settings, as well as third-party data visualisation tools. From one cohesive dashboard users can improve decision-making through the review of key data points and insights.
Shameem C Hameed, founder and CEO of blueBriX, said: “In developing and launching our Patient Support Program and Remote Patient Monitoring features, we can now provide pharma and healthcare providers alike with the technology required to roll out new solutions that will enable patients to easily access support remotely, successfully reducing costs while driving patient education and adherence to improve both outcomes and care.
“We are incredibly excited about this latest tech advancement and are already receiving excellent feedback from existing and potential users alike.”
blueBriX, which has a library of configurable health tech components, expanded into the pharmaceutical sector in May last year, supporting clients to leverage software as a medical device-compliant solutions.